Compound ID | 816
RWJ 306490
Class: Oxazolidinone
| Spectrum of activity: | Gram-positive |
| Institute where first reported: | Johnson & Johnson Pharmaceutical Research & Development, NJ |
| Year first mentioned: | 2000 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/349988068 |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.